UBS Group »

Mural Oncology shares owned by UBS Group

Quarter-by-quarter ownership of Mural Oncology (MURA) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Mural Oncology

Tip: Access up to 7 years of quarterly data

All positions including Mural Oncology held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mural Oncology by UBS Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $100k 20k 4.89
2023-12-31 $79k 13k 5.92

More positions owned by UBS Group

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Amazon Call Option (AMZN)
Ubs Group SHS Call Option (UBS)
JPMorgan Chase & Co. Call Option (JPM)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Meta Platforms Cl A Call Option (META)
Broadcom Call Option (AVGO)
Visa Com Cl A Call Option (V)
Alphabet Cap Stk Cl C Call Option (GOOG)
UnitedHealth Call Option (UNH)

View all positions for UBS Group

Top funds holding Mural Oncology

Armistice Capital
Westfield Capital Management Company
BlackRock
Vanguard Group
Verition Fund Management
Solas Capital Management
Alta Fundamental Advisers
Newtyn Management
Prosight Management
Geode Capital Management
PRIMECAP Management Company
Baker Bros. Advisors
Sonic GP
Nuveen Asset Management
Squarepoint Ops

View all funds holding Mural Oncology